1. Home
  2. WSBC vs GPCR Comparison

WSBC vs GPCR Comparison

Compare WSBC & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WesBanco Inc.

WSBC

WesBanco Inc.

HOLD

Current Price

$42.17

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$53.21

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSBC
GPCR
Founded
1870
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.8B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
WSBC
GPCR
Price
$42.17
$53.21
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$39.25
$103.17
AVG Volume (30 Days)
870.6K
483.2K
Earning Date
04-21-2026
05-08-2026
Dividend Yield
4.48%
N/A
EPS Growth
N/A
N/A
EPS
1.79
N/A
Revenue
N/A
N/A
Revenue This Year
$11.31
N/A
Revenue Next Year
$7.06
N/A
P/E Ratio
$23.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.57
$18.26
52 Week High
$43.02
$94.90

Technical Indicators

Market Signals
Indicator
WSBC
GPCR
Relative Strength Index (RSI) 59.08 55.29
Support Level $38.53 $43.76
Resistance Level N/A $57.15
Average True Range (ATR) 0.62 2.49
MACD -0.10 0.21
Stochastic Oscillator 51.64 68.64

Price Performance

Historical Comparison
WSBC
GPCR

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: